Oxymorphone Extended-Release Tablets and Xultophy
Determining the interaction of Oxymorphone Extended-Release Tablets and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: oxymorphone
Brand name: Opana, Opana ER, Numorphan HCl
Synonyms: Oxymorphone
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Oxymorphone Extended-Release Tablets-Xultophy 100/3.6
- Oxymorphone Extended-Release Tablets-Xuriden
- Oxymorphone Extended-Release Tablets-Xylocaine
- Oxymorphone Extended-Release Tablets-Xylocaine (Cardiac)
- Oxymorphone Extended-Release Tablets-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Oxymorphone Extended-Release Tablets-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-Oxymorphone Hydrochloride
- Xultophy-Oxymorphone Injection
- Xultophy-Oxymorphone Tablets
- Xultophy-Oxytocin
- Xultophy-Oxytocin Intravenous, Intramuscular
- Xultophy-Oxytrol